Jeff Slezak to In Situ Hybridization, Fluorescence
This is a "connection" page, showing publications Jeff Slezak has written about In Situ Hybridization, Fluorescence.
Connection Strength
0.175
-
Correlating routine cytology, quantitative nuclear morphometry by digital image analysis, and genetic alterations by fluorescence in situ hybridization to assess the sensitivity of cytology for detecting pancreatobiliary tract malignancy. Am J Clin Pathol. 2007 Aug; 128(2):272-9.
Score: 0.075
-
Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer. Genes Chromosomes Cancer. 2002 Aug; 34(4):363-71.
Score: 0.053
-
TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors. Cancer Res. 2002 Jul 01; 62(13):3587-91.
Score: 0.013
-
Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression. Mod Pathol. 2002 Jan; 15(1):35-44.
Score: 0.013
-
Fluorescence in situ hybridization aneuploidy as a predictor of clinical disease recurrence and prostate-specific antigen level 3 years after radical prostatectomy. Mayo Clin Proc. 1999 Dec; 74(12):1214-20.
Score: 0.011
-
Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma. J Natl Cancer Inst. 1999 Sep 15; 91(18):1574-80.
Score: 0.011